Advertisement

Topics

UPDATE 1-FDA panel backs Allergan's drug for frequent nightly urination

13:09 EDT 19 Oct 2016 | Reuters

WASHINGTON, Oct 19 (Reuters) - The benefits associated with Allergan Plc's experimental drug to treat frequent nightly urination outweigh the risks for certain patients, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesda...

Original Article: UPDATE 1-FDA panel backs Allergan's drug for frequent nightly urination

NEXT ARTICLE

More From BioPortfolio on "UPDATE 1-FDA panel backs Allergan's drug for frequent nightly urination"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...